ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2621

Venous Claudication Is A Severe and Frequent Symptom In BEHCET’S Syndrome

SerdaL Ugurlu1, Emire Seyahi1, Veysel Oktay2, Zerrin Yigit2, Serdar Kucukoglu2 and Hasan Yazici1, 1Division of Rheumatology,Department of Medicine, Cerrahpasa Medical Faculty, University of Istanbul, Istanbul, Turkey, 2Department of Cardiology, Cardiology Institute, University of Istanbul, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Behcet's syndrome, thrombosis and vasculitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Vasculitis III

Session Type: Abstract Submissions (ACR)

Background/Purpose: In a previous cross-sectional questionnaire survey, we had shown that intermittent claudication was significantly more common among BS patients when compared to healthy controls, and had proposed that this was a “venous claudication” (1) rather than due to atherosclerotic vascular disease since  a. a history of myocardial infarction or angina pectoris were not increased in frequency in the same group of patients as compared to age and sex matched healthy controls; and b. this  intermittent claudication was specifically more common among males with venous thrombosis. The so called venous claudication is thought to be an exercise induced pain resulting from venous outflow impairment (1).  With this study we aimed to 1. To reassess the frequency of venous claudication by a questionnaire survey and 2. To further study this venous claudication prospectively by a formal treadmill exercise in BS patients with and without venous thrombosis along with healthy controls. 

Methods: We studied 59 BS patients with lower extremity venous thrombosis (LEVT), 42 BS patients without venous disease and 55 healthy controls. All patients and controls were male. Patients and controls with peripheral arterial disease were excluded. Intermittent claudication was assessed initially by Rose questionnaire. After this, patients were asked to walk in the treadmill at a set speed of 3.5 km/h and 10% inclination for 10 minutes. Patients who first experienced persistent symptoms consistent with venous claudication but still able to walk and those who had to give up the treadmill were noted. Pre and post-exercise ankle brachial pressure indices (ABPIs) were also measured.

Results: The mean ages of the patients and controls were similar (Table). Pre and post-exercise ABPIs did not differ between patients and controls. There were significantly more patients who described claudication in the questionnaire among those with LEVT (31 %) compared to those with no venous disease (5 %) and healthy controls (0 %) (P<0.001) (Table). Similarly, the number of patients who experienced claudication but still continued to walk on the treadmill were significantly more among those with LEVT. Finally, only those with LEVT had to stop the treadmill challenge due to claudication.  Pre and post exercise ABPI’s were similar among BS patients with LEVT. There was no relation between the presence of vena cava, iliac or femoral vein involvement and the presence of claudication or limitation of walking capacity.

Conclusion: Venous claudication seems to be a severe and frequent symptom being present in up to 1/3 of BS patients with major vein involvement. It clearly limits the walking capacity in 10 % of these patients even when tested in a treadmill set at low pace. 

References: 1) Ugurlu S, et al.. Rheumatology (Oxford). 2008;47:472-5.

Table: Severity and frequency of claudication

BS patients with venous thrombosis

n = 59

BS patients without thrombosis 

           n= 42

Healthy controls

 n = 55

p

Age, mean ± SD, years

37 ± 7

34 ± 7

36 ± 9

0.346

Claudication as assessed by questionnaire, n (%)

18 (31)

2 (5)

0

<0.001

Leg pain during the treadmill exercise (the patient continues to walk)  n (%)

10 (17)

3 (7)

1 (2)    

0.016

Claudication necessating the termination of the  treadmill exercise, n (%)

6 (10)

0

0

0.006


Disclosure:

S. Ugurlu,
None;

E. Seyahi,
None;

V. Oktay,
None;

Z. Yigit,
None;

S. Kucukoglu,
None;

H. Yazici,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/venous-claudication-is-a-severe-and-frequent-symptom-in-behcets-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology